You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Ductal, Breast

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

Completed
Has Results
  • Breast Atypical Ductal Hyperplasia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +5 more
  • Intraoperative Imaging
  • Lumpectomy
  • Chicago, Illinois
  • +3 more
Nov 30, 2022

Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

Not yet recruiting
  • Breast Atypical Hyperplasia
  • +3 more
  • Acolbifene Hydrochloride
  • +4 more
  • Duarte, California
  • +3 more
Jul 11, 2023

Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)

Active, not recruiting
Has Results
  • Breast Cancer
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Carcinoma, Ductal, Breast, Invasive Breast Cancer, IMAGE Trial in Seoul (contrast-enhanced breast MRI)

Completed
  • Carcinoma, Ductal, Breast
  • +2 more
  • contrast-enhanced breast MRI
  • Seoul, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
Feb 25, 2022

Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)

Recruiting
  • Atypical Ductal Hyperplasia
  • Ductal Carcinoma in Situ
  • Vacuum-assisted excisional biopsy
  • Milan, Italy
    Breast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023

Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT

Not yet recruiting
  • Breast Cancer
  • +2 more
  • LS301-IT 0.025 mg/kg
  • +3 more
  • Scottsdale, Arizona
    Integro Theranostics Research Site #1
Jun 2, 2023

Invasive Ductal Breast Carcinoma Trial in Clamart (Degarelix injection(s))

Completed
  • Invasive Ductal Breast Carcinoma
  • Degarelix injection(s)
  • Clamart, France
    Hôpital Antoine Béclère
Sep 26, 2022

Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma Trial in Duarte (Agent Affecting Integumentary System,

Recruiting
  • Breast Ductal Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Agent Affecting Integumentary System
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 30, 2022

Ductal Breast Carcinoma in Situ Trial in Stanford (Lumpectomy, Partial breast irradiation prior to surgery)

Recruiting
  • Ductal Breast Carcinoma in Situ
  • Lumpectomy
  • Partial breast irradiation prior to surgery
  • Stanford, California
    Stanford University
Jan 3, 2022

Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated

Recruiting
  • Ductal Breast Carcinoma in Situ
  • +6 more
  • Hypofractionated radiotherapy
  • Mérida, Yucatán, Mexico
    Unidad Medica de Alta Especialidad
Nov 7, 2022

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,

Active, not recruiting
  • Deleterious BRCA1 Gene Mutation
  • +5 more
  • Behavioral, Psychological or Informational Intervention
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)

Not yet recruiting
  • Ductal Carcinoma in Situ
  • (no location specified)
Oct 13, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Houston, Texas
  • +2 more
Aug 17, 2022

Invasive Ductal Breast Carcinoma, Invasive Ductal Carcinoma, Breast, DCIS Trial in United States (Accelerated Partial Breast

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +5 more
  • Accelerated Partial Breast Irradiation
  • Norwalk, Connecticut
  • +8 more
Oct 4, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Suspended
  • Anatomic Stage I Breast Cancer AJCC v8
  • +23 more
  • Short-Term Fasting
  • Chemotherapy
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Carcinoma, Ductal, Breast, Breast Cancer, Breast Tumor Trial in Worldwide (G1T38, Fulvestrant)

Active, not recruiting
  • Carcinoma, Ductal, Breast
  • +2 more
  • Sofia, Bulgaria
  • +7 more
Aug 1, 2022

Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +14 more
  • Stereotactic body radiotherapy
  • Lattice Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2023

Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)

Completed
  • Carcinoma, Ductal, Breast
  • +6 more
  • Beverly Hills, California
  • +14 more
Dec 14, 2022

Breast Cancer - Ductal Carcinoma in Situ (DCIS), Breast-Conserving Surgery Trial (Histolog Scanner)

Not yet recruiting
  • Breast Cancer - Ductal Carcinoma in Situ (DCIS)
  • Breast-Conserving Surgery
  • Histolog Scanner
  • (no location specified)
Jul 6, 2023

Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • External beam radiation therapy
  • New Brunswick, New Jersey
  • +1 more
Jan 30, 2022

Ductal Carcinoma in Situ Trial in Durham (Decision Support Tool with Active Monitoring, Decision Support Tool without Active

Completed
Has Results
  • Ductal Carcinoma in Situ
  • Decision Support Tool with Active Monitoring
  • Decision Support Tool without Active Monitoring
  • Durham, North Carolina
    Duke Mammography Clinic
Jan 4, 2023

Treating Patients With Stage IV Breast Cancer

Active, not recruiting
  • Central Nervous System Metastases
  • +15 more
  • hyperfractionated radiation therapy
  • +2 more
  • North Chicago, Illinois
    University of Chicago
Dec 6, 2021

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Breast Cancer Female, Stage I Breast Cancer, Stage II Breast Cancer Trial in Austin (Breast reconstruction decision aid,

Completed
  • Breast Cancer Female
  • +6 more
  • Breast reconstruction decision aid
  • Educational website
  • Austin, Texas
    Texas Oncology
Nov 1, 2021